Granules India informs about press release

26 Aug 2022 Evaluate

Granules India has enclosed the press release today titled ‘Granules India Limited Received ANDA Approval for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets’.

The above information is a part of company’s filings submitted to BSE.


Granules India Share Price

596.80 -1.55 (-0.26%)
31-Dec-2025 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.65
Dr. Reddys Lab 1270.50
Cipla 1508.10
Zydus Lifesciences 913.35
Lupin 2111.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×